The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CLOVER HEALTH INVESTMENTS CO | COM CL A | 18914F103 | 1,834,781 | 1,973,944 | SH | SOLE | 1,973,944 | 0 | 0 | ||
| DOMA HOLDINGS INC | COMMON STOCK | 25703A104 | 964,444 | 2,129,485 | SH | SOLE | 2,129,485 | 0 | 0 | ||
| LEMONADE INC | COM | 52567D107 | 5,244,899 | 383,399 | SH | SOLE | 383,399 | 0 | 0 | ||
| KAIROS ACQUISITION CORP | CL A SHS | G52110114 | 19,925,334 | 1,980,000 | SH | SOLE | 1,980,000 | 0 | 0 | ||
| KAIROS ACQUISITION CORP | *W EXP 11/30/202 | G52110106 | 628 | 6,283,265 | SH | SOLE | 6,283,265 | 0 | 0 | ||